Exome Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Exome Asset Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.13M	Hold	576,960	–	–	0.69%	45
2026 Q1	$1.42M	Buy	576,960 +77,373	+15%	+$259K	0.73%	44
2025 Q4	$1.99M	Sell	499,587 -940,017	-65%	-$4.16M	0.95%	42
2025 Q3	$5.44M	Buy	+1,439,604	New	+$4.89M	3.3%	7
2024 Q3	–	Sell	-271,400	Closed	-$453K	–	72
2024 Q2	$453K	Sell	271,400 -54,362	-17%	-$97.1K	0.4%	48
2024 Q1	$606K	Buy	+325,762	New	+$600K	0.52%	49

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

ACM

AIHC Capital Management Central $104M AUM

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Exome Asset Management's NBP Position: Q2 2026 in Review

Exome Asset Management held its NovaBridge Biosciences American Depositary Shares (NBP) position steady in Q2 2026 at 576,960 shares worth $1.13M. The position accounts for 0.69% of the portfolio, ranked #45.

Exome Asset Management first reported a position in NBP in Q1 2024 and has held it in 6 quarters since. The position peaked at $5.44M in Q3 2025. 49 funds tracked by Wall St. Rank hold NBP as of Q2 2026.

Exome Asset Management held 576,960 shares of NovaBridge Biosciences American Depositary Shares worth $1.13M as of Q2 2026.
Exome Asset Management left its NovaBridge Biosciences American Depositary Shares share count unchanged in Q2 2026.
NovaBridge Biosciences American Depositary Shares made up 0.69% of Exome Asset Management's portfolio in Q2 2026, its #45 holding.
Exome Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2024 and has held it in 6 quarters since.
Exome Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $5.44M in Q3 2025.
49 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q2 2026.

Based on Exome Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.